Table of Contents Table of Contents
Previous Page  149 / 242 Next Page
Show Menu
Previous Page 149 / 242 Next Page
Page Background

149

A RANDOMISED CONTROLLED MULTICENTRE TRIAL

11

REFERENCES

1. Chainaki IG, Manolaraki MM, Paspatis G A. Deep sedation for endoscopic retrograde

cholangiopacreatography.

World J Gastrointest Endosc 2011; 3: 34–39

2. Mazanikov M.

Patient-controlled sedation for endoscopic retrograde cholangiopancreatography

.

2013; academic dissertation, Helsinki

3. Kapoor H. Anaesthesia for endoscopic retrograde cholangiopancreatography.

Acta Anaesthesiol Scand 2011; 55: 918–926

4. Hro A, Mann H, Dickersin K, et al. Research and reporting methods annals of internal medicine.

SPIRIT Statement 2013: Defining Standard Protocol Items for Clinical Trials.

Ann Intern Med 2013; 158: 200–207

5. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy

(ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.

Endoscopy 2010; 42: 503–515

6. Absalom A, Mani V, De Smet T, Struys M. Pharmacokinetic models for propofol-defining and

illuminating the devil in the detail.

Br J Anaesth 2009; 103: 26–37

7. Aldrete J. The post anaesthesia recovery score revisited.

J Clin Anesth 1995; 7: 89–91

8. Mortero RF, Clark LD, Tolan MM, et al. The effects of small-dose ketamine on propofol sedation:

respiration, postoperative mood, perception, cognition, and pain.

Anesth Analg 2001; 92: 1465–1469

9. Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardise the reporting and

tracking of adverse events during procedural sedation: a consensus document from the World

SIVA International Sedation Task Force.

Br J Anaesth 2012; 108: 13–20

10. Coté GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol

use during advanced endoscopic procedures.

Clin Gastroenterol Hepatol 2010; 8: 137–142

11. Fanti L, Agostoni M, Arcidiacono PG, et al. Target-controlled infusion duringmonitored anaesthesia

care in patients undergoing EUS: propofol alone versus midazolam plus propofol. A prospective

double-blind randomised controlled trial.

Dig Liver Dis

2007; 39: 81–86

12. Paspatis GA, Manolaraki MM, Vardas E, Theodoropoulou GC. Deep sedation for endoscopic

retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol

with oral midazolam premedication.

Endoscopy 2008; 40: 308–313

13. Varadarajulu S, Eloubeidi MA, Tamhane A, Wilcox CM. Prospective randomised trial evaluating

ketamine for advanced endoscopic procedures in difficult to sedate patients.

Aliment Pharmacol Ther 2007; 25: 987–997

14. Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk

factor analysis.

Scand J Gastroenterol 2008; 43: 368–374

15. Krystal J, Karper LP, Seibyl JP, et al. Subanaesthetic effects of the noncompetitive NMDA antagonist

ketamine in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Arch Gen Psychatrie 1994; 51: 199–214

16. Nakao S, Nagata A, Miyamoto E, et al. Inhibitory effect of propofol on ketamine-induced c-Fos

expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABA receptor

activation.

Acta Anaesthesiol Scand 2003; 47: 284–290